CSF2 and metastatic melanoma: The oncolytic virus originally named OncovexGM-CSF (where GM-CSF is granulocyte-macrophage colony-stimulating factor [GM-CSF]) has been approved by the FDA and the European Medicines Agency (EMA) against metastatic melanoma (13, 14).